- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00710060
Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations
NIMH Collaborative HIV/STD Prevention Trial
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The HIV/AIDS epidemic remains largely out of control in many areas of the world, with an estimated 2.5 million new HIV infections worldwide in 2007. Developing countries with few economic resources and world regions undergoing difficult social transitions have been particularly impacted by large increases in HIV and sexually transmitted disease (STD) infections. To date, effective individual prevention approaches have not been rapid enough to avert the epidemic in these areas and may be too resource intensive to maintain. Behavioral HIV prevention interventions on the community level seek to reduce the prevalence of high-risk sexual behaviors by reaching large numbers of vulnerable people in a cost-effective and feasible manner, even in areas with limited resources. The Community Popular Opinion Leader (C-POL) program is an HIV prevention intervention that recruits and trains trusted opinion leaders in the community to promote safe sex behaviors through risk-reduction conversations with peers. Implementing the C-POL program in world regions facing significant HIV/AIDS epidemics may be the most effective means of encouraging behavior change among members of at-risk populations and strengthening social norms to maintain these changes. This study will evaluate the effectiveness of the C-POL program in promoting safer sexual behaviors and reducing the transmission of HIV/STDs among at-risk populations in China, India, Peru, Russia, and Zimbabwe.
Participation in this study will last 2 years. Initially, an ethnographic study will be conducted to determine the HIV/STD knowledge, attitudes, and behaviors among the population living in the target communities. Information collected via observation, focus groups, and interviews will be used to determine the social risk groups operating within the community and to identify and recruit the opinion leaders who are influential in these groups. Also, an epidemiological study will be conducted to collect information on sexual behaviors and HIV/STD rates.
A cohort of members from participating communities will first undergo baseline assessments that will include a survey about general health and knowledge of HIV/STDs and a biological sampling for HIV/STD testing. Participating communities will then be assigned randomly to receive the C-POL intervention and HIV/STD educational materials or HIV/STD educational materials alone. In communities receiving the C-POL intervention, the previously recruited opinion leaders will be taught skills for sharing HIV risk-reduction messages in daily conversation with peers. This training will occur over four to five weekly sessions. At least 15% of the community population will be trained as opinion leaders. After the initial training, opinion leaders will attend six to nine booster sessions over the next 2 years to reinforce and support continued conversation efforts. Communities assigned to receive the HIV/STD educational materials will receive informational materials on HIV/STDs to provide to community members and will provide treatment or treatment referral for people with nonviral STDs.
All participants in the baseline cohort will be asked to repeat the baseline testing 1 and 2 years later. Participants who are not able to visit a clinic for testing will be contacted by phone to complete the baseline survey. After the 2-year assessments, the C-POL intervention will be conducted in the communities that received educational materials only.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
-
Fuzhou, Cina, 350003
- Fujian Institute of Health Education
-
-
-
-
-
St. Petersburg, Federazione Russa, 197110
- Biomedical Center
-
-
-
-
-
Chennai, India, 600 113
- YRG Centre for AIDS Research and Education (YRGCARE)
-
-
-
-
-
Lima, Perù
- Universidad Peruana Cayetano Heredia
-
-
-
-
-
Harare, Zimbabwe
- Zimbabwe Community Health Intervention Research (ZiCHIRe) - University of Zimbabwe
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Either lives, works, or socializes in the selected venues
- Plans to remain in the venue for at least 1 year after study entry
Exclusion Criteria:
- Permanent disability that hinders participation (e.g. deaf, mental retardation)
- Reports no sex in the 6 months before study entry (China, Peru)
- No STDs present at study entry (China)
- Enrolled in final year of school at time of recruitment (Russia)
- Has lived in venue for less than 2 years (Zimbabwe)
- Lives in venue for less than 9 months out of a year (Zimbabwe)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: 1
Participating communities will receive the Community Popular Opinion Leader intervention and HIV/STD educational materials.
|
The C-POL intervention will teach identified opinion leaders to share personalized HIV prevention messages in conversations with peers in an effort to change community norms.
Opinion leaders will be taught skills for sharing HIV risk-reduction messages during four to five weekly training sessions.
At least 15% of the community population will be trained as opinion leaders.
After the initial training, opinion leaders will attend six to nine booster sessions over the next 2 years to reinforce and support continued conversation efforts.
Altri nomi:
Communities will receive HIV/STD educational materials and treatment referral information to distribute to community members.
|
|
Comparatore attivo: 2
Participating communities will receive HIV/STD educational materials only.
|
Communities will receive HIV/STD educational materials and treatment referral information to distribute to community members.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Frequency of unprotected sexual acts with nonspousal partners
Lasso di tempo: Measured at baseline and Years 1 and 2
|
Measured at baseline and Years 1 and 2
|
|
Overall observed incidence of sexually transmitted diseases (STDs) (e.g., chlamydia, gonorrhea, syphilis, trichomonas, HIV, or herpes simplex virus-2), as detected by biological specimens
Lasso di tempo: Measured at baseline and Years 1 and 2
|
Measured at baseline and Years 1 and 2
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Increased exposure to HIV prevention messages, more STD treatment seeking, lower stigma regarding HIV and STDs, and lower substance abuse associated with sexual behavior in intervention group as compared to control group
Lasso di tempo: Measured at Year 2
|
Measured at Year 2
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Carlos F. Caceres, PhD, Cayetano Heredia University, Lima, Peru
- Investigatore principale: David D. Celentano, ScD, The Johns Hopkins University, Baltimore, Maryland (India)
- Investigatore principale: Thomas J. Coates, PhD, University of California at Los Angeles, Los Angeles, California (Peru)
- Investigatore principale: Tyler D. Hartwell, PhD, RTI International, Research Triangle Park, North Carolina (DCC)
- Investigatore principale: Danuta Kasprzyk, PhD, Battelle Center for Public Health Research and Evaluation, Seattle, Washington (Zimbabwe)
- Investigatore principale: Jeffrey A. Kelly, PhD, Medical College of Wisconsin, Milwaukee, Wisconsin (Russia)
- Investigatore principale: Andrei P. Kozlov, PhD, Biomedical Center, St. Petersburg State University, St. Petersburg, Russia
- Investigatore principale: Willo Pequegnat, PhD, National Institute of Mental Health, Bethesda, Maryland
- Investigatore principale: Mary Jane Rotheram-Borus, PhD, University of California at Los Angeles, Los Angeles, California (China)
- Investigatore principale: Suniti Solomon, MD, YRG Centre for AIDS Research and Education, Chennai, India
- Investigatore principale: Godfrey B. Woelk, PhD, University of Zimbabwe Medical School, Harare, Zimbabwe
- Investigatore principale: Zunyou Wu, MD, PhD, Chinese Center for Disease Control and Prevention, Beijing, P.R. China
Pubblicazioni e link utili
Pubblicazioni generali
- NIMH Collaborative HIV/STD Prevention Trial Group. The community popular opinion leader HIV prevention programme: conceptual basis and intervention procedures. AIDS. 2007 Apr;21 Suppl 2:S59-68. doi: 10.1097/01.aids.0000266458.49138.fa.
- NIMH Collaborative HIV/STD Prevention Trial Group. Formative study conducted in five countries to adapt the community popular opinion leader intervention. AIDS. 2007 Apr;21 Suppl 2:S91-8. doi: 10.1097/01.aids.0000266461.33891.d0.
- NIMH Collaborative HIV/STD Prevention Trial Group. Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial. AIDS. 2007 Apr;21 Suppl 2:S3-18. doi: 10.1097/01.aids.0000266453.18644.27.
- NIMH Collaborative HIV/STD Prevention Trial Group. Selection of populations represented in the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S19-28. doi: 10.1097/01.aids.0000266454.26268.90.
- NIMH Collaborative HIV/STD Prevention Trial Group. Challenges and processes of selecting outcome measures for the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S29-36. doi: 10.1097/01.aids.0000266455.03397.08.
- NIMH Collaborative HIV/STD Prevention Trial Group. Design and integration of ethnography within an international behavior change HIV/sexually transmitted disease prevention trial. AIDS. 2007 Apr;21 Suppl 2(Suppl 2):S37-48. doi: 10.1097/01.aids.0000266456.03397.d3.
- NIMH Collaborative HIV/STD Prevention Trial Group. The feasibility of audio computer-assisted self-interviewing in international settings. AIDS. 2007 Apr;21 Suppl 2:S49-58. doi: 10.1097/01.aids.0000266457.11020.f0.
- NIMH Collaborative HIV/STD Prevention Trial Group. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial. AIDS. 2007 Apr;21 Suppl 2:S69-80. doi: 10.1097/01.aids.0000266459.49138.b3.
- NIMH Collaborative HIV/STD Prevention Trial Group. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings. AIDS. 2007 Apr;21 Suppl 2:S81-90. doi: 10.1097/01.aids.0000266460.56762.84.
- NIMH Collaborative HIV/STD Prevention Trial. Role of the data safety and monitoring board in an international trial. AIDS. 2007 Apr;21 Suppl 2:S99-102. doi: 10.1097/01.aids.0000266462.33891.0b.
- Rotheram-Borus MJ, Wu Z, Liang LJ, Li L, Detels R, Guan J, Yin Y, Swendeman D; NIMH Collaborative HIV/STD Prevention Trial Group. Reductions in sexually transmitted infections associated with popular opinion leaders in China in a randomised controlled trial. Sex Transm Infect. 2011 Jun;87(4):337-43. doi: 10.1136/sti.2010.046243. Epub 2011 Jan 29.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- U10MH061537 (Sovvenzione/contratto NIH degli Stati Uniti)
- DAHBR 9A-ASGT
- U10MH061499 (Sovvenzione/contratto NIH degli Stati Uniti)
- U10MH061513 (Sovvenzione/contratto NIH degli Stati Uniti)
- U10MH061536 (Sovvenzione/contratto NIH degli Stati Uniti)
- U10MH061543 (Sovvenzione/contratto NIH degli Stati Uniti)
- U10MH061544 (Sovvenzione/contratto NIH degli Stati Uniti)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Infezioni da HIV
-
Federal University of São PauloGilead SciencesCompletato
-
University of MinnesotaRitiratoInfezioni da HIV | HIV/AIDS | HIV | AIDS | Problema di Aids/Hiv | AIDS e infezioniStati Uniti
-
National Institute of Allergy and Infectious Diseases...Duke University; Department of Health and Human Services (HHS)Non ancora reclutamento
-
Jecho Biopharmaceuticals Co., Ltd.Non ancora reclutamento
-
Boston UniversityBill and Melinda Gates Foundation; HE2RO, University of the WitwatersrandReclutamento
-
National Institute of Allergy and Infectious Diseases...National Institutes of Health (NIH); Department of Health and Human ServicesReclutamento
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Partners in Hope, Inc.Reclutamento
-
Kelley-Ross & Associates, Inc.Gilead SciencesAttivo, non reclutante
-
Center for Innovative Public Health ResearchNational Institute of Mental Health (NIMH); Makerere University; Internet Solutions...Non ancora reclutamento
Prove cliniche su Community Popular Opinion Leader (C-POL)
-
NICHD Global Network for Women's and Children's...National Cancer Institute (NCI); National Institute of Dental and Craniofacial... e altri collaboratoriCompletato
-
Centers for Disease Control and PreventionUniversity of Alabama at BirminghamCompletatoComportamento a rischio | Malattie trasmesse sessualmenteStati Uniti
-
University of AlbertaPfizer; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation for...CompletatoMalattia coronarica | Cardiopatia ischemicaCanada
-
Centers for Disease Control and PreventionTexas A&M UniversityCompletatoComportamento a rischio | Malattie trasmesse sessualmenteStati Uniti
-
University of AlbertaCanadian Institutes of Health Research (CIHR)Completato
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)Completato
-
Canadian Institutes of Health Research (CIHR)Terminato
-
Medical Research Council, South AfricaLondon School of Hygiene and Tropical Medicine; Johns Hopkins University; Department... e altri collaboratoriCompletatoViolenza intima del partner